ADAGGIO® permite descubrir, gestionar y conectar los resultados y procesos en Ciencia, Tecnología, Innovación y Emprendimiento CTeI+E de su organización al ecosistema digital.
BIOCOMPATIBILIDAD DEL FOSFATO TRICALCICO CON QUITOSANO PARA USO EN REGENERACION OSEA
It is necessary to develop bone grafts capable to regenerate critical size bone defects. Objective: To evaluate the biocompatibility in vivo of tricalcium phosphate with chitosan (TPC) in skin, muscle, and bone. Methods: 15 Wistar rats were assigned to groups A (skin), B (muscle), C, D, and E (bone). TPC was placed in each tissue. In groups C-E, critical size bone defect was grafted with TPC and collagen sponge was placed adjacent to test sites as a control. Animals from groups A and B were sacrificed after 20 days, while groups C-E at days 45, 60, and 80. Inflammatory response was evaluated in all tissues. To assess biocompatibility, the percentage of cells was evaluated as none (0 %), low (˂ 30 %), moderate (30- 50 %), and high (˃50 %). Results: There were no signals of ulceration or suppuration in skin, muscle, and bone. After 80 days, TPC was incorporated into a fibrotic structure and osseointegrated to native bone
Nombre Comercial
Biocompatibility of tricalcium phosphate with chitosan for bone regeneration purposes